OXBDF
Price
$5.35
Change
+$0.15 (+2.88%)
Updated
Dec 12 closing price
PBIGF
Price
$0.14
Change
+$0.03 (+27.27%)
Updated
Oct 30 closing price
Ad is loading...

OXBDF vs PBIGF

Header iconOXBDF vs PBIGF Comparison
Open Charts OXBDF vs PBIGFBanner chart's image
Oxford Biomedica
Price$5.35
Change+$0.15 (+2.88%)
Volume$650
CapitalizationN/A
Paradigm Biopharmaceuticals
Price$0.14
Change+$0.03 (+27.27%)
Volume$30.53K
CapitalizationN/A
OXBDF vs PBIGF Comparison Chart
Loading...
View a ticker or compare two or three
VS
OXBDF vs. PBIGF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OXBDF is a Hold and PBIGF is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (OXBDF: $5.35 vs. PBIGF: $0.14)
Brand notoriety: OXBDF and PBIGF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OXBDF: 36% vs. PBIGF: 128%
Market capitalization -- OXBDF: $572.92M vs. PBIGF: $92.57M
OXBDF [@Biotechnology] is valued at $572.92M. PBIGF’s [@Biotechnology] market capitalization is $92.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OXBDF’s FA Score shows that 0 FA rating(s) are green whilePBIGF’s FA Score has 0 green FA rating(s).

  • OXBDF’s FA Score: 0 green, 5 red.
  • PBIGF’s FA Score: 0 green, 5 red.
According to our system of comparison, OXBDF is a better buy in the long-term than PBIGF.

Price Growth

OXBDF (@Biotechnology) experienced а +2.88% price change this week, while PBIGF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.12%. For the same industry, the average monthly price growth was -2.34%, and the average quarterly price growth was -1.61%.

Industries' Descriptions

@Biotechnology (-7.12% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
OXBDF($573M) has a higher market cap than PBIGF($92.6M). OXBDF YTD gains are higher at: 98.885 vs. PBIGF (-48.685).
OXBDFPBIGFOXBDF / PBIGF
Capitalization573M92.6M619%
EBITDAN/AN/A-
Gain YTD98.885-48.685-203%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
OXBDF: Fundamental Ratings
OXBDF
OUTLOOK RATING
1..100
33
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL248.05-5.43
-2.14%
Apple
SPY586.28-18.01
-2.98%
SPDR® S&P 500® ETF Trust
BTC.X100041.540000-6099.062500
-5.75%
Bitcoin cryptocurrency
TSLA440.13-39.73
-8.28%
Tesla
GME28.55-2.71
-8.67%
GameStop Corp

OXBDF and

Correlation & Price change

A.I.dvisor tells us that OXBDF and SER have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OXBDF and SER's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OXBDF
1D Price
Change %
OXBDF100%
N/A
SER - OXBDF
25%
Poorly correlated
+27.97%
XTLB - OXBDF
24%
Poorly correlated
-4.54%
TBPH - OXBDF
24%
Poorly correlated
-2.51%
ATNM - OXBDF
24%
Poorly correlated
-4.92%
YECO - OXBDF
22%
Poorly correlated
N/A
More

PBIGF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBIGF has been loosely correlated with ABEO. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if PBIGF jumps, then ABEO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBIGF
1D Price
Change %
PBIGF100%
N/A
ABEO - PBIGF
34%
Loosely correlated
-4.25%
STTK - PBIGF
21%
Poorly correlated
-6.09%
ARWR - PBIGF
21%
Poorly correlated
-8.58%
OXBDF - PBIGF
7%
Poorly correlated
N/A
PTCHF - PBIGF
6%
Poorly correlated
N/A
More